Citigroup »

Aeon Biopharma shares owned by Citigroup

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $731 742 0.99

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Aeon Biopharma

Dauntless Investment Group
Vanguard Group
Vanguard Capital Management
Geode Capital Management
XTX Topco
Blue Owl Capital Holdings
BBK Capital Partners
Jane Street
Laird Norton Tyee Trust
Vanguard Fiduciary Trust
LPL Financial
UBS Group
BlackRock
Steward Partners Investment Advisory
Citigroup

View all funds holding Aeon Biopharma